P833: CATEGORIZING HEMATOLOGICAL RESPONSE TO PEGCETACOPLAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A POST HOC ANALYSIS OF THE PHASE 3 PRINCE STUDY DATA

por Risitano, A., Wong, R., Al-Adhami, M., Savage, J., Horneff, R., Peffault de Latour, R.
Publicado 2022

P824: HEMATOLOGIC FEATURES IN 102 FRENCH PATIENTS DIAGNOSED WITH GERMLINE MUTATIONS OF TELOMERES RELATED GENES AGED 15 YEARS OLD OR MORE

por Maillet, F., Galimard, J.-E., Borie, R., Kannengiesser, C., Lainey, E., Peffault De Latour, R., Sicre de Fontbrune, F.
Publicado 2022

S112: COMPARATIVE SCORE OF HOWELL-JOLLY BODIES IN SICKLE CELL DISEASE PATIENTS ACCORDING TO GENOTYPE, AGE, SPLENECTOMY OR STEM CELL TRANSPLANTATION HISTORY

por Bernaudin, F, Arnaud, C, Kamdem, A, Pondarré, C, Hau, I, Lelong, F, Dalle, J, Peffault de Latour, R, Lezeau, H
Publicado 2022

Disseminated cutaneous infection due to Mycobacterium chelonae following hematopoietic stem cell transplantation

por Ferry, C., Saussine, A., Bouaziz, J.D., Xhaard, A., Peffault de Latour, R., Ribaud, P., Robin, M., Cambau, E., Socié, G.
Publicado 2014

Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis

por Bergeron, A, Godet, C, Chevret, S, Lorillon, G, Peffault de Latour, R, de Revel, T, Robin, M, Ribaud, P, Socié, G, Tazi, A
Publicado 2012

P828: NORMALIZATION OF HEMATOLOGIC AND HEALTH-RELATED QUALITY OF LIFE MARKERS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH PEGCETACOPLAN AND BASELINE HEMOGLOBI...

por Panse, J., Daguindau, N., Okuyama, S., Peffault de Latour, R., Schafhausen, P., Straetmans, N., Al-Adhami, M., Ajayi, T., Persson, E., Yeh, M., Wong, R.
Publicado 2022

P1355: VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION (HCT): OUTCOMES OF DEFIBROTIDE-TREATED ADULT PATIENTS FR...

por Mohty, M., Yakoub-Agha, I., Dalle, J.-H., Labopin, M., Cornillon, J., Huynh, A., Lamy, T., Soussain, C., Asubonteng, K., Gutierrez, D., Peffault de Latour, R.
Publicado 2022

P812: LONG-TERM COMPLEMENT INHIBITION AND SURVIVAL OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: AN INTERIM ANALYSIS OF THE RAVULIZUMAB CLINICAL TRIALS

por Kulasekararaj, A., Brodsky, R., Griffin, M., Kulagin, A., Ogawa, M., Wang, J., Mujeebuddin, A., Nishimura, J.-I., Peffault de Latour, R., Szer, J., Lee, J. W.
Publicado 2022

P1469: LONGITUDINAL SICKLE CELL DISEASE COHORT-STUDY: IN CHILDREN WITH SPLENIC SEQUESTRATION HISTORY OR HYPERSPLENISM, PARTIAL VS TOTAL SPLENECTOMY BEFORE STEM CELL TRANSPLANTATION...

por Bernaudin, F., Arnaud, C., Kamdem, A., Pondarré, C., Hau, I., Bayani, N., Kuentz, M., Gluckman, E., Peffault de Latour, R., Dhédin, N., Lezeau, H., Dalle, J.-H.
Publicado 2022

The first steps towards a diverse and inclusive EBMT: a position paper

por Montoto, S., Snowden, J. A., Chabannon, C., Corbacioglu, S., de la Camara, R., Dolstra, H., Greco, R., Gusi, A., Hamad, N., Kenyon, M., Kröger, N., Mohty, M., Murray, J., Mueller, A., Neven, B., Peffault de Latour, R., Peric, Z., Sánchez-Ortega, I., Sureda, A., Verhoeven, B., Villar, A., Yakoub-Agha, I.
Publicado 2022